Patents by Inventor Adnan Salameh

Adnan Salameh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190240252
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: February 4, 2019
    Publication date: August 8, 2019
    Inventors: Stephen Randall HOLMES-FARLEY, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
  • Publication number: 20160158275
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: December 14, 2015
    Publication date: June 9, 2016
    Inventors: Stephen Randall HOLMES-FARLEY, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
  • Publication number: 20150283170
    Abstract: The present invention relates to polycarbophil coated crosslinked amine polymers and/or pharmaceutical compositions comprising polycarbophil coated crosslinked amine polymers. The polycarbophil coated crosslinked amine polymers have several therapeutic applications, including, but not limited to, hyperphosphatemia, chronic kidney disease and End-Stage Renal Disease.
    Type: Application
    Filed: April 7, 2014
    Publication date: October 8, 2015
    Applicant: GENZYME CORPORATION
    Inventors: Hitesh BHAGAT, Adnan SALAMEH
  • Publication number: 20140322319
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m particles and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 30, 2014
    Applicant: GENZYME CORPORATION
    Inventors: Stephen Randall Holmes-Farley, David J. HARRIS, Steven C. POLOMOSCANIK, Adnan SALAMEH, Bruce SHUTTS, Richard SILVA, Pradeep K. DHAL, Lynne SOLE
  • Publication number: 20110142952
    Abstract: This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol. % of the particles have a particle size greater than 500 ?m.
    Type: Application
    Filed: June 17, 2009
    Publication date: June 16, 2011
    Inventors: David J. Harris, Stephen Randall Holmes-Farley, Steven C. Polomoscanlk, Adnan Salameh, Bruce Shutts, Richard Silva
  • Publication number: 20100316589
    Abstract: The present invention relates to polycarbophil coated crosslinked amine polymers and/or pharmaceutical compositions comprising polycarbophil coated crosslinked amine polymers. The polycarbophil coated crosslinked amine polymers have several therapeutic applications, including, but not limited to, hyperphosphatemia, chronic kidney disease and End-Stage Renal Disease.
    Type: Application
    Filed: December 12, 2008
    Publication date: December 16, 2010
    Inventors: Hitesh Bhagat, Adnan Salameh
  • Publication number: 20090155368
    Abstract: The present invention relates to crosslinked polyamine particles and/or pharmaceutical compositions comprising, at least in part, crosslinked polyamine particles and aggregates of such particles (including cured aggregates of crosslinked polyamine particles). The compositions may be in the form of tablets comprising, for example, particles larger than 500 ?m, and used for treating patients, for example, patients with hyperphosphatemia.
    Type: Application
    Filed: December 12, 2008
    Publication date: June 18, 2009
    Applicant: Genzyme Corporation
    Inventors: Stephen Randall Holmes-Farley, David J. Harris, Steven C. Polomoscanik, Adnan Salameh, Bruce Shutts, Richard Silva, Pradeep K. Dhal, Lynne Sole